Wakefield Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,550
Closed -$847K 217
2024
Q4
$847K Sell
2,550
-11
-0.4% -$3.73K 0.29% 111
2024
Q3
$855K Sell
2,561
-24
-0.9% -$9.12K 0.28% 106
2024
Q2
$1.06M Sell
2,585
-32
-1% -$12.7K 0.37% 74
2024
Q1
$1.06M Sell
2,617
-990
-27% -$348K 0.37% 77
2023
Q4
$1.11M Buy
3,607
+351
+11% +$94.7K 0.41% 67
2023
Q3
$788K Sell
3,256
-161
-5% -$41.2K 0.36% 74
2023
Q2
$821K Buy
3,417
+13
+0.4% +$2.7K 0.33% 86
2023
Q1
$640K Sell
3,404
-162
-5% -$33.5K 0.27% 111
2022
Q4
$757K Sell
3,566
-1,858
-34% -$371K 0.32% 101
2022
Q3
$852K Sell
5,424
-21
-0.4% -$3.35K 0.39% 66
2022
Q2
$815K Buy
+5,445
New +$788K 0.35% 73
2019
Q4
Sell
-6,714
Closed -$564K 178
2019
Q3
$564K Buy
+6,714
New +$507K 0.25% 94
2019
Q2
Sell
-32
Closed -$2K 211
2019
Q1
$2K Sell
32
-8,079
-100% -$483K ﹤0.01% 197
2018
Q4
$429K Buy
8,111
+3,705
+84% +$203K 0.19% 100
2018
Q3
$264K Buy
+4,406
New +$241K 0.1% 113

Other funds holding MEDP

Wakefield Asset Management's MEDP Position: Q1 2025 in Review

Wakefield Asset Management sold out of Medpace (MEDP) in Q1 2025, closing a stake of 2,550 shares — an estimated $847K sold.

Wakefield Asset Management first reported a position in MEDP in Q3 2018 and held it in 15 quarters. The position peaked at $1.11M in Q4 2023. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Wakefield Asset Management reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
  • Wakefield Asset Management sold 2,550 Medpace shares in Q1 2025, an estimated $847K.
  • Wakefield Asset Management first reported a position in Medpace in Q3 2018 and held it in 15 quarters.
  • Wakefield Asset Management's Medpace position peaked at $1.11M in Q4 2023.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Wakefield Asset Management's 13F filing for Q1 2025, filed 6 May 2025.